| Serial Number | 97063826 |
| Word Mark | S SHACKELFORD PHARMA |
| Filing Date | Thursday, October 7, 2021 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Friday, November 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of a large stylized "S" with upper and lower portions forming a plus sign design in its center with the wording "Shackelford" to the right and above the wording "Pharma," with the "S" in "Shackelford" and the "P" in "Pharma" each capitalized with the remaining lettering in lowercase. |
| Goods and Services | Pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration |
| Goods and Services | (Based on 44(d) Priority Application) (Based on Intent to Use) Providing consumer, business and industry information to the public in the fields of medical cannabis, the treatment of medical conditions, and research in the field of medical marijuana |
| NOT AVAILABLE | "PHARMA" |
| Goods and Services | (Based on 44(d) Priority Application) (Based on Intent to Use) Providing information to the public in the field of scientific and medical research in the field of medical marijuana; Providing information to the public in the field of scientific and medical research in the field of neurological diseases and disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 1, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 1, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 1, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Shackelford Pharma Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | British Columbia V6C2G8 CA |
| Event Date | Event Description |
| Monday, October 11, 2021 | NEW APPLICATION ENTERED |
| Monday, November 1, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 2, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, April 10, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, April 11, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, April 11, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, April 11, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, July 7, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, July 7, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, October 10, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, February 29, 2024 | ASSIGNED TO LIE |
| Thursday, February 29, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 29, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 26, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, August 26, 2024 | FINAL REFUSAL WRITTEN |
| Monday, August 26, 2024 | FINAL REFUSAL E-MAILED |
| Friday, November 15, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, November 15, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 15, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, November 18, 2024 | ASSIGNED TO EXAMINER |
| Friday, November 22, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, November 22, 2024 | LETTER OF SUSPENSION E-MAILED |
| Friday, November 22, 2024 | SUSPENSION LETTER WRITTEN |